Literature DB >> 8536738

Cryptococcal meningitis following fludarabine treatment for chronic lymphocytic leukemia.

A Leenders, P Sonneveld, S de Marie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8536738     DOI： 10.1007/bf01691005

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine.

Authors:  C Sanders; E A Perez; H J Lawrence
Journal:  Am J Hematol       Date:  1992-04       Impact factor: 10.047

2.  Flow cytometric analysis of T-lymphocyte subpopulations in B-cell chronic lymphocytic leukemia: correlation with clinical stage.

Authors:  M L Hautekeete; R F De Bock; D R Van Bockstaele; G C Colpin; Z N Berneman; M E Peetermans
Journal:  Blut       Date:  1987-11

3.  Acquired immunodeficiency without evidence of HIV infection: national retrospective survey.

Authors:  A McNulty; J M Kaldor; A M McDonald; K Baumgart; D A Cooper
Journal:  BMJ       Date:  1994-03-26

4.  Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.

Authors:  M J Keating; H Kantarjian; M Talpaz; J Redman; C Koller; B Barlogie; W Velasquez; W Plunkett; E J Freireich; K B McCredie
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

5.  Severe immunodeficiency in patients treated with fludarabine monophosphate.

Authors:  P W Wijermans; W B Gerrits; H L Haak
Journal:  Eur J Haematol       Date:  1993-05       Impact factor: 2.997

6.  Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

Authors:  S O'Brien; H Kantarjian; M Beran; T Smith; C Koller; E Estey; L E Robertson; S Lerner; M Keating
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

7.  Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.

Authors:  E Anaissie; D P Kontoyiannis; H Kantarjian; L Elting; L E Robertson; M Keating
Journal:  Ann Intern Med       Date:  1992-09-15       Impact factor: 25.391

8.  Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection.

Authors:  D D Ho; Y Cao; T Zhu; C Farthing; N Wang; G Gu; R T Schooley; E S Daar
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

9.  Cryptococcal meningitis in patients with AIDS.

Authors:  W E Dismukes
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

10.  Effects on human peripheral lymphocytes of in vivo administration of 9-beta-D-arabinofuranosyl-2-fluoroadenine-5'-monophosphate (NSC 312887), a new purine antimetabolite.

Authors:  D H Boldt; D D Von Hoff; J G Kuhn; M Hersh
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701
  10 in total
  2 in total

Review 1.  Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors:  J C Adkins; D H Peters; A Markham
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 2.  Achieving optimal outcomes in chronic lymphocytic leukaemia.

Authors:  T J Hamblin
Journal:  Drugs       Date:  2001       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.